Prevention of N-Methyl-d-Aspartate-Induced Mechanical Nociception by Intrathecal Administration of Ketoprofen and Ketamine in Sheep
Authors:
- Ignacio LizarragaILIgnacio Lizarraga
- J Paul ChambersJCJ Paul Chambers
- Craig B. JohnsonCJCraig B. Johnson
- 1 December 2008
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 107 (6) , 2061-2067
Abstract
Nonsteroidal antiinflammatory drugs and N-methyl-d-aspartate (NMDA) receptor antagonists reduce pain hypersensitivity when given by the intrathecal (i.t.) route, but their combined effects have hardly been studied. We assessed the effects of the nonsteroidal antiinflammatory drug ketoprofen and the NMDA receptor channel blocker ketamine, given alone and in combination, on mechanical nociceptive thresholds in sheep implanted with indwelling cervical i.t. catheters. Sheep were given, by i.t. catheter, ketoprofen (200–3200 μM; 100 μL) and ketamine (25–400 μM; 100 μL) alone or in combination (837.95–3350.78 μM; 100 μL; 0.955:0.045 proportion). They also received NMDA (2 mM; 100 μL) preceded by the highest concentration of ketoprofen and ketamine alone or in combination. Saline solution (0.9%; 100 μL) and xylazine (1.95 mM; 100 μL) were used as negative and positive controls, respectively. Xylazine significantly increased the area under the nociceptive threshold versus time curve values (AUC) for 30, 60, and 180 min posttreatment. Ketoprofen and ketamine, alone and in combination, produced no significant effect on AUC values. NMDA alone decreased the AUC value for 30 min posttreatment. This pain hypersensitivity was prevented by preadministering ketoprofen and ketamine alone and in combination. In sheep, i.t. administration of ketoprofen and ketamine, alone or together, produced no hypoalgesia; however, they prevented NMDA-induced mechanical hypersensitivity. Ketoprofen and ketamine may have therapeutic potential in conditions associated with persistent pain.Keywords
This publication has 21 references indexed in Scilit:
- Synergistic depression of NMDA receptor‐mediated transmission by ketamine, ketoprofen andL‐NAME combinations in neonatal rat spinal cordsin vitroBritish Journal of Pharmacology, 2008
- Involvement of opioidergic and α2-adrenergic mechanisms in the central analgesic effects of non-steroidal anti-inflammatory drugs in sheepResearch in Veterinary Science, 2006
- Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer painPain, 2005
- The Spinal Phospholipase-Cyclooxygenase-Prostanoid Cascade in Nociceptive ProcessingAnnual Review of Pharmacology and Toxicology, 2002
- The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1Journal of Neuroscience, 2001
- The Role of Nitric Oxide and Prostaglandin E2 on the Hyperalgesia Induced by Excitatory Amino Acids in RatsJournal of Pharmacy and Pharmacology, 2000
- Histological Findings After Long-Term Infusion of Intrathecal Ketamine for Chronic PainJournal of Pain and Symptom Management, 1999
- N-methyl D-aspartate induced mechanical allodynia is blocked by nitric oxide synthase and cyclooxygenase-2 inhibitorsNeuroReport, 1999
- Chronic intrathecal catheterization in the sheepJournal of Pharmacological and Toxicological Methods, 1992
- Small Intrathecal Doses of Lysine-Acetylsalicylate Relieve Intractable Pain in ManJournal of International Medical Research, 1983